stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / WST / Revenue

West Pharmaceutical Services, Inc. Revenue 2008–2025

West Pharmaceutical Services, Inc. (WST) annual revenue by fiscal year, computed from SEC filings. Compound growth +6.5%/yr over 17 years.

Fiscal yearRevenueChange (YoY)
FY 2025$3.07B+6.3%
FY 2024$2.89B-1.9%
FY 2023$2.95B+2.2%
FY 2022$2.89B+2.0%
FY 2021$2.83B+31.9%
FY 2020$2.15B+16.7%
FY 2019$1.84B+7.1%
FY 2018$1.72B+7.4%
FY 2017$1.60B+6.0%
FY 2016$1.51B+7.8%
FY 2015$1.40B-1.5%
FY 2014$1.42B+3.9%
FY 2013$1.37B+8.1%
FY 2012$1.27B+6.2%
FY 2011$1.19B+7.9%
FY 2010$1.10B+4.6%
FY 2009$1.06B+0.4%
FY 2008$1.05B

Source: West Pharmaceutical Services, Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for West Pharmaceutical Services, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

West Pharmaceutical Services, Inc. — frequently asked questions

What is West Pharmaceutical Services, Inc.'s revenue?

West Pharmaceutical Services, Inc. (WST) reported revenue of $3.07B for fiscal year 2025, per its SEC filings.

How has West Pharmaceutical Services, Inc.'s revenue changed over time?

Between fiscal 2008 and 2025, WST's revenue grew at roughly 6.5% per year (compound annual rate), from $1.05B to $3.07B.

Where does this data come from?

Figures are computed from West Pharmaceutical Services, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More WST financial history

Full WST fundamentals page → · All 1,500+ companies →